Aug 1 (Reuters) - Drugmaker Regeneron Pharmaceuticals (REGN.O), opens new tab exceeded estimates for second-quarter revenue and profit on Thursday, driven by strong demand for its top-selling eczema ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback